Sign in to see private stats on your profile page — or add photo, interests, videos, mentoring, etc.

    I-Chow Hsu, MD

    TitleProfessor
    SchoolUCSF School of Medicine
    DepartmentRadiation Oncology
    Address1600 Divisadero
    San Francisco CA 94115
    Phone415-353-7106
    vCardDownload vCard

      Collapse Biography 
      Collapse Education and Training
      Johns HopkinsM.D.Medicine1991
      University of FloridaB.S.Biochemistry1987
      Collapse Awards and Honors
      2006ARRO Teacher of the Year
      2008Lawrence Margolis Lifetime Teaching Award
      2008ARRO Teacher of the Year
      2009ARRO Teacher of the Year
      2010Fellow of American College of Radiology
      2014Fellow of American Society for Radiation Oncology

      Collapse Overview 
      Collapse Interests
      HDR Brachytherapy, Hyperthermia, Urological Oncology, Gynecological Oncology

      Collapse ORNG Applications 
      Collapse Websites
      Collapse Clinical Trials
      Collapse Featured Publications

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Crehange G, Izaguirre A, Weinberg V, Hsu CC, Gottschalk AR, Hsu IC, Shinohara K, Carroll P, Roach M. Long-term Outcomes Following Radiation Therapy For Prostate Cancer Patients With Lymph Node Metastases at Diagnosis Treated With and Without Surgery. Am J Clin Oncol. 2016 Apr; 39(2):167-72. PMID: 24441584.
        View in: PubMed
      2. Anwar M, Weinberg V, Seymour Z, Hsu IJ, Roach M, Gottschalk AR. Outcomes of hypofractionated stereotactic body radiotherapy boost for intermediate and high-risk prostate cancer. Radiat Oncol. 2016; 11(1):8. PMID: 26792201.
        View in: PubMed
      3. Raleigh DR, Chang AJ, Tomlin B, Cunha JA, Braunstein SE, Shinohara K, Gottschalk AR, Roach M, Hsu IC. Patient- and treatment-specific predictors of genitourinary function after high-dose-rate monotherapy for favorable prostate cancer. Brachytherapy. 2015 Nov-Dec; 14(6):795-800. PMID: 26198421.
        View in: PubMed
      4. Tinkle CL, Weinberg V, Chen LM, Littell R, Cunha JA, Sethi RA, Chan JK, Hsu IC. Inverse Planned High-Dose-Rate Brachytherapy for Locoregionally Advanced Cervical Cancer: 4-Year Outcomes. Int J Radiat Oncol Biol Phys. 2015 Aug 1; 92(5):1093-100. PMID: 26194683.
        View in: PubMed
      5. Hsu CC, Paciorek AT, Cooperberg MR, Roach M, Hsu IC, Carroll PR. Postoperative radiation therapy for patients at high-risk of recurrence after radical prostatectomy: does timing matter? BJU Int. 2015 Nov; 116(5):713-20. PMID: 25600860.
        View in: PubMed
      6. Seymour ZA, Chang AJ, Zhang L, Kirby N, Descovich M, Roach M, Hsu IC, Gottschalk AR. Dose-volume analysis and the temporal nature of toxicity with stereotactic body radiation therapy for prostate cancer. Pract Radiat Oncol. 2015 Sep-Oct; 5(5):e465-72. PMID: 25795252.
        View in: PubMed
      7. Cunha JA, Mellis K, Sethi R, Siauw T, Sudhyadhom A, Garg A, Goldberg K, Hsu IC, Pouliot J. Evaluation of PC-ISO for customized, 3D Printed, gynecologic 192-Ir HDR brachytherapy applicators. J Appl Clin Med Phys. 2015; 16(1):5168. PMID: 25679174.
        View in: PubMed
      8. Raleigh DR, Hsu IC, Braunstein S, Chang AJ, Simko JP, Roach M. Bladder wall recurrence of prostate cancer after high-dose-rate brachytherapy. Brachytherapy. 2015 Mar-Apr; 14(2):185-8. PMID: 25533416.
        View in: PubMed
      9. Gustafson GS, Nguyen PL, Assimos DG, D'Amico AV, Gottschalk AR, Hsu IC, Lloyd S, Mclaughlin PW, Merrick GS, Showalter TN, Taira AV, Vapiwala N, Yamada Y, Davis BJ. ACR appropriateness Criteria® Postradical prostatectomy irradiation in prostate cancer. Oncology (Williston Park). 2014 Dec; 28(12):1125-30, 1132-6. PMID: 25510812.
        View in: PubMed
      10. Zagar TM, Vujaskovic Z, Formenti S, Rugo H, Muggia F, O'Connor B, Myerson R, Stauffer P, Hsu IC, Diederich C, Straube W, Boss MK, Boico A, Craciunescu O, Maccarini P, Needham D, Borys N, Blackwell KL, Dewhirst MW. Two phase I dose-escalation/pharmacokinetics studies of low temperature liposomal doxorubicin (LTLD) and mild local hyperthermia in heavily pretreated patients with local regionally recurrent breast cancer. Int J Hyperthermia. 2014 Aug; 30(5):285-94. PMID: 25144817; PMCID: PMC4162656.
      11. Alexander J, Weinberg V, Gottschalk AR, Hsu IC, Shinohara K, Roach M. Pre-plan parameters predict post-implant D90 = 140 Gy for (125)I permanent prostate implants. J Contemp Brachytherapy. 2014 Jun; 6(2):143-53. PMID: 25097554; PMCID: PMC4105644.
      12. Nguyen PL, Aizer A, Assimos DG, D'Amico AV, Frank SJ, Gottschalk AR, Gustafson GS, Hsu IC, McLaughlin PW, Merrick G, Rosenthal SA, Showalter TN, Taira AV, Vapiwala N, Yamada Y, Davis BJ. ACR Appropriateness Criteria® Definitive External-Beam Irradiation in stage T1 and T2 prostate cancer. Am J Clin Oncol. 2014 Jun; 37(3):278-88. PMID: 25180754.
        View in: PubMed
      13. Hsu IC, Yamada Y, Assimos DG, D'Amico AV, Davis BJ, Frank SJ, Gottschalk AR, Gustafson GS, McLaughlin PW, Nguyen PL, Rosenthal SA, Taira AV, Vapiwala N, Merrick G. Response to Drs Rogers, Hayes, and Demanes. Brachytherapy. 2014 Sep-Oct; 13(5):523-5. PMID: 24880587.
        View in: PubMed
      14. Chen CP, Braunstein S, Mourad M, Hsu IC, Haas-Kogan D, Roach M, Fogh SE. Quality improvement of International Classification of Diseases, 9th revision, diagnosis coding in radiation oncology: single-institution prospective study at University of California, San Francisco. Pract Radiat Oncol. 2015 Jan-Feb; 5(1):e45-51. PMID: 25413428.
        View in: PubMed
      15. Salgaonkar VA, Prakash P, Rieke V, Ozhinsky E, Plata J, Kurhanewicz J, Hsu IC, Diederich CJ. Model-based feasibility assessment and evaluation of prostate hyperthermia with a commercial MR-guided endorectal HIFU ablation array. Med Phys. 2014 Mar; 41(3):033301. PMID: 24593742; PMCID: PMC3987720.
      16. Nattagh K, Siauw T, Pouliot J, Hsu IC, Cunha JA. A training phantom for ultrasound-guided needle insertion and suturing. Brachytherapy. 2014 Jul-Aug; 13(4):413-9. PMID: 24529964.
        View in: PubMed
      17. Thomadsen BR, Erickson BA, Eifel PJ, Hsu IC, Patel RR, Petereit DG, Fraass BA, Rivard MJ. A review of safety, quality management, and practice guidelines for high-dose-rate brachytherapy: executive summary. Pract Radiat Oncol. 2014 Mar-Apr; 4(2):65-70. PMID: 24890345.
        View in: PubMed
      18. Anwar M, Weinberg V, Chang AJ, Hsu IC, Roach M, Gottschalk A. Hypofractionated SBRT versus conventionally fractionated EBRT for prostate cancer: comparison of PSA slope and nadir. Radiat Oncol. 2014; 9:42. PMID: 24484652; PMCID: PMC3923240.
      19. Hsu IC, Hunt D, Straube, W, Pouliot J, Cunha A, Krishnamurthy D, Sandler H. . Dosimetric Analysis of Radiation Therapy Oncology Group 0321: The Importance of Urethral Dose. Practical Radiation Oncology. 2014; 4:27-34.
      20. Hsu IC, Yamada Y, Assimos DG, D'Amico AV, Davis BJ, Frank SJ, Gottschalk AR, Gustafson GS, McLaughlin PW, Nguyen PL, Rosenthal SA, Taira AV, Vapiwala N, Merrick G. ACR Appropriateness Criteria high-dose-rate brachytherapy for prostate cancer. Brachytherapy. 2014 Jan-Feb; 13(1):27-31. PMID: 24368283.
        View in: PubMed
      21. Myerson RJ, Moros EG, Diederich CJ, Haemmerich D, Hurwitz MD, Hsu IC, McGough RJ, Nau WH, Straube WL, Turner PF, Vujaskovic Z, Stauffer PR. Components of a hyperthermia clinic: recommendations for staffing, equipment, and treatment monitoring. Int J Hyperthermia. 2014 Feb; 30(1):1-5. PMID: 24350642.
        View in: PubMed
      22. Crehange G, Krishnamurthy D, Cunha JA, Pickett B, Kurhanewicz J, Hsu IC, Gottschalk AR, Shinohara K, Roach M, Pouliot J. Cold spot mapping inferred from MRI at time of failure predicts biopsy-proven local failure after permanent seed brachytherapy in prostate cancer patients: implications for focal salvage brachytherapy. Radiother Oncol. 2013 Nov; 109(2):246-50. PMID: 24231238; PMCID: PMC4081029.
      23. Salgaonkar VA, Rieke V, Ozhinsky E, Prakash P, Plata J, Kurhanewicz J, Hsu IC, Diederich CJ. Model-based feasibility assessment and evaluation of prostate hyperthermia with a commercial MRI-guided endorectal high intensity focused ultrasound ablation array. J Acoust Soc Am. 2013 Nov; 134(5):4180. PMID: 24181657.
        View in: PubMed
      24. Pinnaduwage DS, Cunha JA, Weinberg V, Krishnamurthy D, Nash M, Hsu IC, Pouliot J. A dosimetric evaluation of using a single treatment plan for multiple treatment fractions within a given applicator insertion in gynecologic brachytherapy. Brachytherapy. 2013 Sep-Oct; 12(5):487-94. PMID: 23582467.
        View in: PubMed
      25. Hsu IC, Hunt D, Straube W, Pouliot J, Cunha A, Krishnamurthy D, Sandler H. Dosimetric analysis of radiation therapy oncology group 0321: the importance of urethral dose. Pract Radiat Oncol. 2014 Jan-Feb; 4(1):27-34. PMID: 24621420; PMCID: PMC4000550.
      26. Cury FL, Hunt D, Roach M, Shipley W, Gore E, Hsu IC, Krisch RE, Seider MJ, Sandler H, Lawton C. Prostate-specific antigen response after short-term hormone therapy plus external-beam radiotherapy and outcome in patients treated on Radiation Therapy Oncology Group study 9413. Cancer. 2013 Jun 1; 119(11):1999-2004. PMID: 23504930; PMCID: PMC3663874.
      27. Chen CP, Weinberg V, Shinohara K, Roach M, Nash M, Gottschalk A, Chang AJ, Hsu IC. Salvage HDR brachytherapy for recurrent prostate cancer after previous definitive radiation therapy: 5-year outcomes. Int J Radiat Oncol Biol Phys. 2013 Jun 1; 86(2):324-9. PMID: 23474112.
        View in: PubMed
      28. Pejavar S, Yom SS, Hwang A, Speight J, Gottschalk A, Hsu IC, Roach M, Xia P. Computer-assisted, atlas-based segmentation for target volume delineation in whole pelvic IMRT for prostate cancer. Technol Cancer Res Treat. 2013 Jun; 12(3):199-206. PMID: 23289478.
        View in: PubMed
      29. Siauw T, Cunha A, Berenson D, Atamturk A, Hsu IC, Goldberg K, Pouliot J. NPIP: A skew line needle configuration optimization system for HDR brachytherapy. Med Phys. 2012 Jul; 39(7):4339-46. PMID: 22830767.
        View in: PubMed
      30. Hsu CC, Hsu H, Pickett B, Crehange G, Hsu IC, Dea R, Weinberg V, Gottschalk AR, Kurhanewicz J, Shinohara K, Roach M. Feasibility of MR imaging/MR spectroscopy-planned focal partial salvage permanent prostate implant (PPI) for localized recurrence after initial PPI for prostate cancer. Int J Radiat Oncol Biol Phys. 2013 Feb 1; 85(2):370-7. PMID: 22672747.
        View in: PubMed
      31. Abdel-Wahab M, Mahmoud O, Merrick G, Hsu IC, Arterbery VE, Ciezki JP, Frank SJ, Mohler JL, Moran BJ, Rosenthal SA, Rossi CJ, Yamada Y. ACR Appropriateness Criteria® external-beam radiation therapy treatment planning for clinically localized prostate cancer. J Am Coll Radiol. 2012 Apr; 9(4):233-8. PMID: 22469373.
        View in: PubMed
      32. Yamada Y, Rogers L, Demanes DJ, Morton G, Prestidge BR, Pouliot J, Cohen GN, Zaider M, Ghilezan M, Hsu IC. American Brachytherapy Society consensus guidelines for high-dose-rate prostate brachytherapy. Brachytherapy. 2012 Jan-Feb; 11(1):20-32. PMID: 22265435.
        View in: PubMed
      33. Moran BJ, DeRose P, Hsu IC, Abdel-Wahab M, Arterbery VE, Ciezki JP, Frank SJ, Mohler JL, Rosenthal SA, Rossi CJ, Yamada Y, Merrick GS. ACR Appropriateness Criteria® definitive external beam irradiation in stage T1 and T2 prostate cancer. Am J Clin Oncol. 2011 Dec; 34(6):636-47. PMID: 22101389.
        View in: PubMed
      34. Shiao SL, Sahgal A, Hu W, Jabbari S, Chuang C, Descovich M, Hsu IC, Gottschalk AR, Roach M, Ma L. Temporal compartmental dosing effects for robotic prostate stereotactic body radiotherapy. Phys Med Biol. 2011 Dec 21; 56(24):7767-75. PMID: 22107791.
        View in: PubMed
      35. Cunha JA, Pouliot J, Weinberg V, Wang-Chesebro A, Roach M, Hsu IC. Urethra low-dose tunnels: validation of and class solution for generating urethra-sparing dose plans using inverse planning simulated annealing for prostate high-dose-rate brachytherapy. Brachytherapy. 2012 Sep-Oct; 11(5):348-53. PMID: 21937284.
        View in: PubMed
      36. Ciezki JP, Hsu IC, Abdel-Wahab M, Arterbery VE, Frank SJ, Mohler JL, Moran BJ, Rosenthal SA, Rossi CJ, Yamada Y, Merrick G. American College of Radiology Appropriateness Criteria(®)--locally advanced (high-risk) prostate cancer. Clin Oncol (R Coll Radiol). 2012 Feb; 24(1):43-51. PMID: 21875782.
        View in: PubMed
      37. Siauw T, Cunha A, Atamtürk A, Hsu IC, Pouliot J, Goldberg K. IPIP: A new approach to inverse planning for HDR brachytherapy by directly optimizing dosimetric indices. Med Phys. 2011 Jul; 38(7):4045-51. PMID: 21859003.
        View in: PubMed
      38. Wootton JH, Prakash P, Hsu IC, Diederich CJ. Implant strategies for endocervical and interstitial ultrasound hyperthermia adjunct to HDR brachytherapy for the treatment of cervical cancer. Phys Med Biol. 2011 Jul 7; 56(13):3967-84. PMID: 21666290.
        View in: PubMed
      39. Frank SJ, Arterbery VE, Hsu IC, Abdel-Wahab M, Ciezki JP, Hahn NM, Mohler JL, Moran BJ, Rosenthal SA, Rossi CJ, Yamada Y, Merrick G. American College of Radiology Appropriateness Criteria permanent source brachytherapy for prostate cancer. Brachytherapy. 2011 Sep-Oct; 10(5):357-62. PMID: 21497562.
        View in: PubMed
      40. Reed G, Cunha JA, Noworolski S, Kurhanewicz J, Vigneron D, Hsu IC, Pouliot J. Interactive, multi-modality image registrations for combined MRI/MRSI-planned HDR prostate brachytherapy. J Contemp Brachytherapy. 2011 Mar 31; 3(1):26-31. PMID: 23606866.
        View in: PubMed
      41. Krishnamurthy D, Weinberg V, Cunha JA, Hsu IC, Pouliot J. Comparison of high-dose rate prostate brachytherapy dose distributions with iridium-192, ytterbium-169, and thulium-170 sources. Brachytherapy. 2011 Nov-Dec; 10(6):461-5. PMID: 21397569.
        View in: PubMed
      42. Wootton JH, Hsu IC, Diederich CJ. Endocervical ultrasound applicator for integrated hyperthermia and HDR brachytherapy in the treatment of locally advanced cervical carcinoma. Med Phys. 2011 Feb; 38(2):598-611. PMID: 21452697; PMCID: PMC3033875.
      43. Jabbari S, Weinberg VK, Kaprealian T, Hsu IC, Ma L, Chuang C, Descovich M, Shiao S, Shinohara K, Roach M, Gottschalk AR. Stereotactic body radiotherapy as monotherapy or post-external beam radiotherapy boost for prostate cancer: technique, early toxicity, and PSA response. Int J Radiat Oncol Biol Phys. 2012 Jan 1; 82(1):228-34. PMID: 21183287.
        View in: PubMed
      44. Kaprealian T, Weinberg V, Speight JL, Gottschalk AR, Roach M, Shinohara K, Hsu IC. High-dose-rate brachytherapy boost for prostate cancer: comparison of two different fractionation schemes. Int J Radiat Oncol Biol Phys. 2012 Jan 1; 82(1):222-7. PMID: 21163586.
        View in: PubMed
      45. Erickson BA, Demanes DJ, Ibbott GS, Hayes JK, Hsu IC, Morris DE, Rabinovitch RA, Tward JD, Rosenthal SA. American Society for Radiation Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys. 2011 Mar 1; 79(3):641-9. PMID: 21106308.
        View in: PubMed
      46. Cunha JA, Hsu IC, Pouliot J, Roach Iii M, Shinohara K, Kurhanewicz J, Reed G, Stoianovici D. Toward adaptive stereotactic robotic brachytherapy for prostate cancer: demonstration of an adaptive workflow incorporating inverse planning and an MR stealth robot. Minim Invasive Ther Allied Technol. 2010 Aug; 19(4):189-202. PMID: 20642386; PMCID: PMC3108452.
      47. Foster W, Cunha JA, Hsu IC, Weinberg V, Krishnamurthy D, Pouliot J. Dosimetric impact of interfraction catheter movement in high-dose rate prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2011 May 1; 80(1):85-90. PMID: 20605353.
        View in: PubMed
      48. Hsu IC, Bae K, Shinohara K, Pouliot J, Purdy J, Ibbott G, Speight J, Vigneault E, Ivker R, Sandler H. Phase II trial of combined high-dose-rate brachytherapy and external beam radiotherapy for adenocarcinoma of the prostate: preliminary results of RTOG 0321. Int J Radiat Oncol Biol Phys. 2010 Nov 1; 78(3):751-8. PMID: 20207506; PMCID: PMC2946454.
      49. Aubry JF, Cheung J, Morin O, Beaulieu L, Hsu IC, Pouliot J. Investigation of geometric distortions on magnetic resonance and cone beam computed tomography images used for planning and verification of high-dose rate brachytherapy cervical cancer treatment. Brachytherapy. 2010 Jul-Sep; 9(3):266-73. PMID: 20149759.
        View in: PubMed
      50. Chen X, Diederich CJ, Wootton JH, Pouliot J, Hsu IC. Optimisation-based thermal treatment planning for catheter-based ultrasound hyperthermia. Int J Hyperthermia. 2010 Feb; 26(1):39-55. PMID: 20100052.
        View in: PubMed
      51. Jabbari S, Weinberg VK, Shinohara K, Speight JL, Gottschalk AR, Hsu IC, Pickett B, McLaughlin PW, Sandler HM, Roach M. Equivalent biochemical control and improved prostate-specific antigen nadir after permanent prostate seed implant brachytherapy versus high-dose three-dimensional conformal radiotherapy and high-dose conformal proton beam radiotherapy boost. Int J Radiat Oncol Biol Phys. 2010 Jan 1; 76(1):36-42. PMID: 19409729.
        View in: PubMed
      52. Schmid S, Hsu IC, Hu JM, Sherman AE, Osann K, Kapp DS, Chan JK. Adjuvant radiation therapy in stage III node-positive uterine cancer. Gynecol Oncol. 2009 Nov; 115(2):239-43. PMID: 19679341.
        View in: PubMed
      53. Jabbari S, Hsu IC, Kawakami J, Weinberg VK, Speight JL, Gottschalk AR, Roach M, Shinohara K. High-dose-rate brachytherapy for localized prostate adenocarcinoma post abdominoperineal resection of the rectum and pelvic irradiation: Technique and experience. Brachytherapy. 2009 Oct-Dec; 8(4):339-44. PMID: 19428310.
        View in: PubMed
      54. Kim DH, Wang-Chesebro A, Weinberg V, Pouliot J, Chen LM, Speight J, Littell R, Hsu IC. High-dose rate brachytherapy using inverse planning simulated annealing for locoregionally advanced cervical cancer: a clinical report with 2-year follow-up. Int J Radiat Oncol Biol Phys. 2009 Dec 1; 75(5):1329-34. PMID: 19409728.
        View in: PubMed
      55. Westphalen AC, Kurhanewicz J, Cunha RM, Hsu IC, Kornak J, Zhao S, Coakley FV. T2-Weighted endorectal magnetic resonance imaging of prostate cancer after external beam radiation therapy. Int Braz J Urol. 2009 Mar-Apr; 35(2):171-80; discussion 181-2. PMID: 19409121; PMCID: PMC4532331.
      56. Aaronson DS, Yamasaki I, Gottschalk A, Speight J, Hsu IC, Pickett B, Roach M, Shinohara K. Salvage permanent perineal radioactive-seed implantation for treating recurrence of localized prostate adenocarcinoma after external beam radiotherapy. BJU Int. 2009 Sep; 104(5):600-4. PMID: 19245439.
        View in: PubMed
      57. Xu J, Duindam V, Alterovitz R, Pouliot J, Cunha JA, Hsu IC, Goldberg K. Planning Fireworks Trajectories for Steerable Medical Needles to Reduce Patient Trauma. Rep U S. 2009; 4517-4522. PMID: 25946259.
        View in: PubMed
      58. Cunha JA, Hsu IC, Pouliot J. Dosimetric equivalence of nonstandard HDR brachytherapy catheter patterns. Med Phys. 2009 Jan; 36(1):233-9. PMID: 19235391.
        View in: PubMed
      59. Alterovitz R, Goldberg KY, Pouliot J, Hsu IC. Sensorless motion planning for medical needle insertion in deformable tissues. IEEE Trans Inf Technol Biomed. 2009 Mar; 13(2):217-25. PMID: 19126473; PMCID: PMC2822650.
      60. Sahgal A, Jabbari S, Chen J, Pickett B, Roach M, Weinberg V, Hsu IC, Pouliot J. Comparison of dosimetric and biologic effective dose parameters for prostate and urethra using 131 Cs and 125 I for prostate permanent implant brachytherapy. Int J Radiat Oncol Biol Phys. 2008 Sep 1; 72(1):247-54. PMID: 18722275.
        View in: PubMed
      61. Joseph T, McKenna DA, Westphalen AC, Coakley FV, Zhao S, Lu Y, Hsu IC, Roach M, Kurhanewicz J. Pretreatment endorectal magnetic resonance imaging and magnetic resonance spectroscopic imaging features of prostate cancer as predictors of response to external beam radiotherapy. Int J Radiat Oncol Biol Phys. 2009 Mar 1; 73(3):665-71. PMID: 18760545; PMCID: PMC2737354.
      62. Kubicky CD, Yeh BM, Lessard E, Joe BN, Speight JL, Pouliot J, Hsu IC. Inverse planning simulated annealing for magnetic resonance imaging-based intracavitary high-dose-rate brachytherapy for cervical cancer. Brachytherapy. 2008 Jul-Sep; 7(3):242-7. PMID: 18468959.
        View in: PubMed
      63. Chan LW, Xia P, Gottschalk AR, Akazawa M, Scala M, Pickett B, Hsu IC, Speight J, Roach M. Proposed rectal dose constraints for patients undergoing definitive whole pelvic radiotherapy for clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 2008 Sep 1; 72(1):69-77. PMID: 18342454.
        View in: PubMed
      64. Kim Y, Hsu IC, Lessard E, Kurhanewicz J, Noworolski SM, Pouliot J. Class solution in inverse planned HDR prostate brachytherapy for dose escalation of DIL defined by combined MRI/MRSI. Radiother Oncol. 2008 Jul; 88(1):148-55. PMID: 18083260; PMCID: PMC4523126.
      65. Kim Y, Hsu IC, Pouliot J. Measurement of craniocaudal catheter displacement between fractions in computed tomography-based high dose rate brachytherapy of prostate cancer. J Appl Clin Med Phys. 2007; 8(4):2415. PMID: 18449148.
        View in: PubMed
      66. Schiffner DC, Gottschalk AR, Lometti M, Aubin M, Pouliot J, Speight J, Hsu IC, Shinohara K, Roach M. Daily electronic portal imaging of implanted gold seed fiducials in patients undergoing radiotherapy after radical prostatectomy. Int J Radiat Oncol Biol Phys. 2007 Feb 1; 67(2):610-9. PMID: 17236978.
        View in: PubMed
      67. Lee B, Shinohara K, Weinberg V, Gottschalk AR, Pouliot J, Roach M, Hsu IC. Feasibility of high-dose-rate brachytherapy salvage for local prostate cancer recurrence after radiotherapy: the University of California-San Francisco experience. Int J Radiat Oncol Biol Phys. 2007 Mar 15; 67(4):1106-12. PMID: 17197119.
        View in: PubMed
      68. Alterovitz R, Lessard E, Pouliot J, Hsu IC, O'Brien JF, Goldberg K. Optimization of HDR brachytherapy dose distributions using linear programming with penalty costs. Med Phys. 2006 Nov; 33(11):4012-9. PMID: 17153381.
        View in: PubMed
      69. Alterovitz R, Goldberg K, Pouliot J, Hsu IC, Kim Y, Noworolski SM, Kurhanewicz J. Registration of MR prostate images with biomechanical modeling and nonlinear parameter estimation. Med Phys. 2006 Feb; 33(2):446-54. PMID: 16532952.
        View in: PubMed
      70. Kim Y, Hsu IC, Pouliot J, Noworolski SM, Vigneron DB, Kurhanewicz J. Expandable and rigid endorectal coils for prostate MRI: impact on prostate distortion and rigid image registration. Med Phys. 2005 Dec; 32(12):3569-78. PMID: 16475755.
        View in: PubMed
      71. Dewitt KD, Hsu IC, Speight J, Weinberg VK, Lessard E, Pouliot J. 3D inverse treatment planning for the tandem and ovoid applicator in cervical cancer. Int J Radiat Oncol Biol Phys. 2005 Nov 15; 63(4):1270-4. PMID: 16253782.
        View in: PubMed
      72. Sumida I, Shiomi H, Yoshioka Y, Inoue T, Lessard E, Hsu IC, Pouliot J. Optimization of dose distribution for HDR brachytherapy of the prostate using Attraction-Repulsion Model. Int J Radiat Oncol Biol Phys. 2006 Feb 1; 64(2):643-9. PMID: 16289907.
        View in: PubMed
      73. Hsu IC, Cabrera AR, Weinberg V, Speight J, Gottschalk AR, Roach M, Shinohara K. Combined modality treatment with high-dose-rate brachytherapy boost for locally advanced prostate cancer. Brachytherapy. 2005; 4(3):202-6. PMID: 16182220.
        View in: PubMed
      74. Kim Y, Hsu IC, Lessard E, Pouliot J, Vujic J. Dose uncertainty due to computed tomography (CT) slice thickness in CT-based high dose rate brachytherapy of the prostate cancer. Med Phys. 2004 Sep; 31(9):2543-8. PMID: 15487736.
        View in: PubMed
      75. Taschereau R, Stauffer PR, Hsu IC, Schlorff JL, Milligan AJ, Pouliot J. Radiation dosimetry of a conformal heat-brachytherapy applicator. Technol Cancer Res Treat. 2004 Aug; 3(4):347-58. PMID: 15270585.
        View in: PubMed
      76. Pouliot J, Kim Y, Lessard E, Hsu IC, Vigneron DB, Kurhanewicz J. Inverse planning for HDR prostate brachytherapy used to boost dominant intraprostatic lesions defined by magnetic resonance spectroscopy imaging. Int J Radiat Oncol Biol Phys. 2004 Jul 15; 59(4):1196-207. PMID: 15234056.
        View in: PubMed
      77. Kim Y, Hsu IC, Lessard E, Vujic J, Pouliot J. Dosimetric impact of prostate volume change between CT-based HDR brachytherapy fractions. Int J Radiat Oncol Biol Phys. 2004 Jul 15; 59(4):1208-16. PMID: 15234057.
        View in: PubMed
      78. Hsu IC, Lessard E, Weinberg V, Pouliot J. Comparison of inverse planning simulated annealing and geometrical optimization for prostate high-dose-rate brachytherapy. Brachytherapy. 2004; 3(3):147-52. PMID: 15533807.
        View in: PubMed
      79. Alterovitz R, Goldberg K, Kurhanewicz J, Pouliot J, Hsu IC. Image registration for prostate MR spectroscopy using modeling and optimization of force and stiffness parameters. Conf Proc IEEE Eng Med Biol Soc. 2004; 3:1722-5. PMID: 17272037.
        View in: PubMed
      80. Langen KM, Pouliot J, Anezinos C, Aubin M, Gottschalk AR, Hsu IC, Lowther D, Liu YM, Shinohara K, Verhey LJ, Weinberg V, Roach M. Evaluation of ultrasound-based prostate localization for image-guided radiotherapy. Int J Radiat Oncol Biol Phys. 2003 Nov 1; 57(3):635-44. PMID: 14529767.
        View in: PubMed
      81. Charra-Brunaud C, Hsu IC, Weinberg V, Pouliot J. Analysis of interaction between number of implant catheters and dose-volume histograms in prostate high- dose-rate brachytherapy using a computer model. Int J Radiat Oncol Biol Phys. 2003 Jun 1; 56(2):586-91. PMID: 12738336.
        View in: PubMed
      82. Alterovitz R, Pouliot J, Taschereau R, Hsu IC, Goldberg K. Simulating needle insertion and radioactive seed implantation for prostate brachytherapy. Stud Health Technol Inform. 2003; 94:19-25. PMID: 15455857.
        View in: PubMed
      83. Lessard E, Hsu IC, Pouliot J. Inverse planning for interstitial gynecologic template brachytherapy: truly anatomy-based planning. Int J Radiat Oncol Biol Phys. 2002 Nov 15; 54(4):1243-51. PMID: 12419454.
        View in: PubMed
      84. Lachance B, Béliveau-Nadeau D, Lessard E, Chrétien M, Hsu IC, Pouliot J, Beaulieu L, Vigneault E. Early clinical experience with anatomy-based inverse planning dose optimization for high-dose-rate boost of the prostate. Int J Radiat Oncol Biol Phys. 2002 Sep 1; 54(1):86-100. PMID: 12182978.
        View in: PubMed
      85. Hsu IC, Speight J, Hai J, Vigneault E, Phillips T, Pouliot J. A comparison between tandem and ovoids and interstitial gynecologic template brachytherapy dosimetry using a hypothetical computer model. Int J Radiat Oncol Biol Phys. 2002 Feb 1; 52(2):538-43. PMID: 11872302.
        View in: PubMed
      86. Lee N, Hoffman R, Phillips TL, Xia P, Quivey JM, Weinberg V, Hsu IC. Managing nasopharyngeal carcinoma with intracavitary brachytherapy: one institution's 45-year experience. Brachytherapy. 2002; 1(2):74-82. PMID: 15062174.
        View in: PubMed
      87. Speight JL, Shinohara K, Pickett B, Weinberg VK, Hsu IC, Roach M. Prostate volume change after radioactive seed implantation: possible benefit of improved dose volume histogram with perioperative steroid. Int J Radiat Oncol Biol Phys. 2000 Dec 1; 48(5):1461-7. PMID: 11121649.
        View in: PubMed
      88. Hsu IC, Pickett B, Shinohara K, Krieg R, Roach M, Phillips T. Normal tissue dosimetric comparison between HDR prostate implant boost and conformal external beam radiotherapy boost: potential for dose escalation. Int J Radiat Oncol Biol Phys. 2000 Mar 1; 46(4):851-8. PMID: 10705005.
        View in: PubMed
      89. Ingenito AC, Ennis RD, Hsu IC, Begg MD, Benson MC, Schiff PB. Re-examining the role of prostate-specific antigen density in predicting outcome for clinically localized prostate cancer. Urology. 1997 Jul; 50(1):73-8. PMID: 9218022.
        View in: PubMed
      I-Chow's Networks
      Related Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors
      People in Profiles who have published with this person.
      _
      Related Authors
      People who share related concepts with this person.
      _
      Back to TOP